Temat: "Platelet Aggregation Inhibitors" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Platelet reactivity testing in peripheral artery disease.
Autorzy:: Zhang Y; Department of Pharmacy, Oregon Health & Science University, Portland, OR, USA.
Chou JW; Department of Pharmacy, UC San Diego Health, La Jolla, CA, USA.
Huang WT; Department of Pharmacy, UC San Diego Health, La Jolla, CA, USA.
Derry K; Department of Pharmacy, UC San Diego Health, La Jolla, CA, USA.
Humber D; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, USA.; Pokaż więcej
Źródło:: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2022 Aug 05; Vol. 79 (16), pp. 1312-1322.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Peripheral Arterial Disease*/diagnosis
Peripheral Arterial Disease*/drug therapy
Platelet Aggregation Inhibitors*/therapeutic use
Blood Platelets ; Clopidogrel ; Humans ; Purinergic P2Y Receptor Antagonists/pharmacology ; Purinergic P2Y Receptor Antagonists/therapeutic use ; Ticlopidine/adverse effects ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Antiplatelet therapy with or without anticoagulant therapy for lower extremity peripheral artery disease: A systematic review.
Autorzy:: Rahmatian D; (PharmD for Pharmacists student), Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada, and St. Paul's Hospital, Lower Mainland Pharmacy Services, Vancouver, Canada.
Barry AR; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada, and Chilliwack General Hospital, Lower Mainland Pharmacy Services, Chilliwack, Canada.; Pokaż więcej
Źródło:: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2021 Nov 23; Vol. 78 (23), pp. 2132-2141.
Typ publikacji:: Journal Article; Systematic Review
MeSH Terms:: Peripheral Arterial Disease*/drug therapy
Platelet Aggregation Inhibitors*/adverse effects
Anticoagulants/adverse effects ; Drug Therapy, Combination ; Factor Xa Inhibitors ; Humans ; Lower Extremity/blood supply ; Lower Extremity/surgery ; Rivaroxaban/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Antithrombotic selection in patients undergoing transcatheter aortic valve replacement.
Autorzy:: Lai JK; Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison, WI.
Willenborg KL; Department of Pharmacy, William S. Middleton Memorial Veterans Hospital, Madison, WI.
Berei T; Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison, WI.
Rose AE; Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison, WI.; Pokaż więcej
Źródło:: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2021 Jan 01; Vol. 78 (1), pp. 22-35.
Typ publikacji:: Journal Article
MeSH Terms:: Anticoagulants*/adverse effects
Fibrinolytic Agents*/adverse effects
Hemorrhage*/chemically induced
Platelet Aggregation Inhibitors*/adverse effects
Transcatheter Aortic Valve Replacement*/adverse effects
Aortic Valve/surgery ; Humans ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Aspirin rechallenge in an adult patient previously diagnosed with Reye syndrome.
Autorzy:: Magrum BG; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH.
Pickworth KK; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH.; Pokaż więcej
Źródło:: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2020 Jan 08; Vol. 77 (2), pp. 123-127.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Acute Coronary Syndrome/*drug therapy
Aspirin/*therapeutic use
Platelet Aggregation Inhibitors/*therapeutic use
Reye Syndrome/*complications
Acute Coronary Syndrome/complications ; Aspirin/administration & dosage ; Humans ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/administration & dosage ; Survivors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting.
Autorzy:: Lacoste JL; Department of Pharmacy, WVU Medicine, Morgantown, WV.
Hansen CL; BCPS AQ-Cardiology, Intermountain Healthcare-Utah Valley Hospital, Provo, UT.; Pokaż więcej
Źródło:: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2019 Sep 03; Vol. 76 (18), pp. 1395-1402.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Anticoagulants/*administration & dosage
Atrial Fibrillation/*surgery
Percutaneous Coronary Intervention/*adverse effects
Platelet Aggregation Inhibitors/*administration & dosage
Thrombosis/*prevention & control
Administration, Oral ; Anticoagulants/adverse effects ; Atrial Fibrillation/complications ; Blood Loss, Surgical/prevention & control ; Blood Loss, Surgical/statistics & numerical data ; Clinical Decision-Making ; Coronary Artery Disease/complications ; Coronary Artery Disease/surgery ; Drug Administration Schedule ; Drug Therapy, Combination/adverse effects ; Drug Therapy, Combination/methods ; Humans ; Patient Preference ; Percutaneous Coronary Intervention/instrumentation ; Platelet Aggregation Inhibitors/adverse effects ; Postoperative Hemorrhage/epidemiology ; Postoperative Hemorrhage/etiology ; Postoperative Hemorrhage/prevention & control ; Practice Guidelines as Topic ; Risk Assessment ; Stents ; Thrombosis/etiology ; Time Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: A Validated LC-MS/MS Method for the Simultaneous Determination of Ticagrelor, Its Two Metabolites and Major Constituents of Tea Polyphenols in Rat Plasma and Its Application in a Pharmacokinetic Study.
Autorzy:: Xue Y; Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi District, Zhengzhou 450052, China.
Wang Z; Department of Clinical Pharmacy, School of Pharmacy, Fudan University, No. 826 Zhangheng Road, Pudong New Area, Shanghai 201203, China.
Cai W; Department of Clinical Pharmacy, School of Pharmacy, Fudan University, No. 826 Zhangheng Road, Pudong New Area, Shanghai 201203, China.
Tian X; Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi District, Zhengzhou 450052, China.
Liu S; Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi District, Zhengzhou 450052, China.; Pokaż więcej
Źródło:: Journal of chromatographic science [J Chromatogr Sci] 2021 May 20; Vol. 59 (6), pp. 510-520.
Typ publikacji:: Journal Article; Validation Study
MeSH Terms:: Platelet Aggregation Inhibitors/*blood
Polyphenols/*blood
Tandem Mass Spectrometry/*methods
Ticagrelor/*blood
Animals ; Chromatography, Liquid/methods ; Limit of Detection ; Male ; Rats, Sprague-Dawley ; Tea/chemistry ; Rats

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation?
Autorzy:: Basaraba JE; Mazankowski Alberta Heart Institute, Alberta Health Services, Edmonton, Canada, and Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada.
Barry AR; Lower Mainland Pharmacy Services, Chilliwack, Canada, and Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada. .; Pokaż więcej
Źródło:: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2016 May 01; Vol. 73 (9), pp. e229-37.
Typ publikacji:: Journal Article; Meta-Analysis; Review
MeSH Terms:: Aspirin/*administration & dosage
Drug-Eluting Stents/*trends
Percutaneous Coronary Intervention/*trends
Platelet Aggregation Inhibitors/*administration & dosage
Ticlopidine/*analogs & derivatives
Aspirin/adverse effects ; Clopidogrel ; Drug Administration Schedule ; Drug-Eluting Stents/adverse effects ; Hemorrhage/chemically induced ; Humans ; Percutaneous Coronary Intervention/adverse effects ; Platelet Aggregation Inhibitors/adverse effects ; Randomized Controlled Trials as Topic/methods ; Thrombosis/etiology ; Thrombosis/prevention & control ; Ticlopidine/administration & dosage ; Ticlopidine/adverse effects ; Time Factors

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Vorapaxar for reduction of thrombotic cardiovascular events in myocardial infarction and peripheral artery disease.
Autorzy:: Arif SA; Sally A. Arif, Pharm.D., BCPS (AQ-Cardiology), is Associate Professor of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University, Downers Grove, IL, and Clinical Pharmacist, Department of Pharmacy, Rush University Medical Center, Chicago, IL. Jennifer D'Souza, Pharm.D., CDE, BC-ADM, is Associate Professor of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University. Monika Gil, Pharm.D., BCPS, is Clinical Pharmacist, Department of Pharmacy, Rush University Medical Center. Suzanna Gim, B.A., Pharm.D., M.P.H., is Associate Professor of Pharmacy Practice, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, and Drug Information Specialist, Brookdale University Hospital and Medical Center, Brooklyn. .
D'Souza J; Sally A. Arif, Pharm.D., BCPS (AQ-Cardiology), is Associate Professor of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University, Downers Grove, IL, and Clinical Pharmacist, Department of Pharmacy, Rush University Medical Center, Chicago, IL. Jennifer D'Souza, Pharm.D., CDE, BC-ADM, is Associate Professor of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University. Monika Gil, Pharm.D., BCPS, is Clinical Pharmacist, Department of Pharmacy, Rush University Medical Center. Suzanna Gim, B.A., Pharm.D., M.P.H., is Associate Professor of Pharmacy Practice, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, and Drug Information Specialist, Brookdale University Hospital and Medical Center, Brooklyn.
Gil M; Sally A. Arif, Pharm.D., BCPS (AQ-Cardiology), is Associate Professor of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University, Downers Grove, IL, and Clinical Pharmacist, Department of Pharmacy, Rush University Medical Center, Chicago, IL. Jennifer D'Souza, Pharm.D., CDE, BC-ADM, is Associate Professor of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University. Monika Gil, Pharm.D., BCPS, is Clinical Pharmacist, Department of Pharmacy, Rush University Medical Center. Suzanna Gim, B.A., Pharm.D., M.P.H., is Associate Professor of Pharmacy Practice, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, and Drug Information Specialist, Brookdale University Hospital and Medical Center, Brooklyn.
Gim S; Sally A. Arif, Pharm.D., BCPS (AQ-Cardiology), is Associate Professor of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University, Downers Grove, IL, and Clinical Pharmacist, Department of Pharmacy, Rush University Medical Center, Chicago, IL. Jennifer D'Souza, Pharm.D., CDE, BC-ADM, is Associate Professor of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University. Monika Gil, Pharm.D., BCPS, is Clinical Pharmacist, Department of Pharmacy, Rush University Medical Center. Suzanna Gim, B.A., Pharm.D., M.P.H., is Associate Professor of Pharmacy Practice, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, and Drug Information Specialist, Brookdale University Hospital and Medical Center, Brooklyn.; Pokaż więcej
Źródło:: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2015 Oct 01; Vol. 72 (19), pp. 1615-22.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Lactones/*pharmacology
Lactones/*therapeutic use
Platelet Aggregation Inhibitors/*pharmacology
Platelet Aggregation Inhibitors/*therapeutic use
Pyridines/*pharmacology
Pyridines/*therapeutic use
Thrombosis/*prevention & control
Aspirin/administration & dosage ; Clopidogrel ; Drug Interactions ; Drug Therapy, Combination ; Half-Life ; Hemorrhage/chemically induced ; Humans ; Lactones/adverse effects ; Lactones/pharmacokinetics ; Myocardial Infarction/epidemiology ; Myocardial Ischemia/prevention & control ; Peripheral Arterial Disease/epidemiology ; Platelet Aggregation Inhibitors/adverse effects ; Platelet Aggregation Inhibitors/pharmacokinetics ; Pyridines/adverse effects ; Pyridines/pharmacokinetics ; Randomized Controlled Trials as Topic ; Receptor, PAR-1/antagonists & inhibitors ; Secondary Prevention ; Stroke/prevention & control ; Ticlopidine/administration & dosage ; Ticlopidine/analogs & derivatives

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Comparative resource utilization and costs for patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with clopidogrel or prasugrel.
Autorzy:: Bae JP; Eli Lilly and Company, Indianapolis, IN. bae_.
Faries DE; Eli Lilly and Company, Indianapolis, IN.
Ernst FR; Indegene Total Therapeutic Management, Kennesaw, GA.
Lipkin C; Premier Research Services, Premier Healthcare Alliance, Charlotte, NC.
Zhao Z; Eli Lilly and Company, Indianapolis, IN.
Moretz C; Comprehensive Health Insights, a Humana Company, Louisville, KY.
Lieu HD; Eli Lilly and Company, Indianapolis, IN.
Effron MB; Eli Lilly and Company, Indianapolis, IN.; Pokaż więcej
Źródło:: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2016 Mar 15; Vol. 73 (6), pp. 395-403.
Typ publikacji:: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hospital Costs*/trends
Acute Coronary Syndrome/*economics
Percutaneous Coronary Intervention/*economics
Platelet Aggregation Inhibitors/*economics
Prasugrel Hydrochloride/*economics
Ticlopidine/*analogs & derivatives
Acute Coronary Syndrome/diagnosis ; Acute Coronary Syndrome/therapy ; Aged ; Clopidogrel ; Databases, Factual/trends ; Disease Management ; Female ; Health Resources/economics ; Health Resources/trends ; Hemorrhage/chemically induced ; Hemorrhage/economics ; Humans ; Length of Stay/trends ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/adverse effects ; Platelet Aggregation Inhibitors/therapeutic use ; Prasugrel Hydrochloride/adverse effects ; Prasugrel Hydrochloride/therapeutic use ; Ticlopidine/adverse effects ; Ticlopidine/economics ; Ticlopidine/therapeutic use ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Defibrotide for the Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2 Pediatric Patients.
Autorzy:: Lang P; Children's University Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Eichholz T; Children's University Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Bakchoul T; Institute of Transfusion Medicine, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Streiter M; Children's Hospital, SLK-Kliniken Heilbronn GmbH, Heilbronn, Germany.
Petrasch M; Children's Hospital, SLK-Kliniken Heilbronn GmbH, Heilbronn, Germany.
Bösmüller H; Institute of Pathology, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Klein R; Department of Haematology/Oncology, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Rabsteyn A; Children's University Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Lang AM; Children's University Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Adams C; Children's University Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Klingel K; Institute of Pathology, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Gessner M; Children's University Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Rosenberger P; University Hospital for Intensive Care and Anaesthesiology, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Ruef P; Children's Hospital, SLK-Kliniken Heilbronn GmbH, Heilbronn, Germany.
Handgretinger R; Children's University Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Pokaż więcej
Źródło:: Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2020 Nov 10; Vol. 9 (5), pp. 622-625.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Coronavirus Infections/*complications
Platelet Aggregation Inhibitors/*therapeutic use
Pneumonia, Viral/*complications
Polydeoxyribonucleotides/*therapeutic use
Systemic Inflammatory Response Syndrome/*drug therapy
Abdominal Pain/etiology ; Adolescent ; Betacoronavirus ; Blood Coagulation Factors/analysis ; COVID-19 ; Child ; Coronavirus Infections/diagnosis ; Female ; Fever/etiology ; Humans ; Pandemics ; Pneumonia, Viral/diagnosis ; SARS-CoV-2 ; Systemic Inflammatory Response Syndrome/blood ; Systemic Inflammatory Response Syndrome/immunology ; T-Lymphocytes/immunology
SCR Disease Name:: pediatric multisystem inflammatory disease, COVID-19 related

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.
Autorzy:: Davis KA; Kyle A. Davis, Pharm.D., BCPS, is Clinical Hospital Pharmacist, Internal Medicine; and Marta A. Miyares, Pharm.D., BCPS (AQ-Cardiology), CACP, is Clinical Hospital Pharmacist, Internal Medicine, Jackson Memorial Hospital, Miami, FL. Eric Dietrich, Pharm.D., BCPS, is Clinical Assistant Professor, Department of Community Health and Family Medicine, College of Medicine, and Clinical Assistant Professor, Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville. .
Miyares MA; Kyle A. Davis, Pharm.D., BCPS, is Clinical Hospital Pharmacist, Internal Medicine; and Marta A. Miyares, Pharm.D., BCPS (AQ-Cardiology), CACP, is Clinical Hospital Pharmacist, Internal Medicine, Jackson Memorial Hospital, Miami, FL. Eric Dietrich, Pharm.D., BCPS, is Clinical Assistant Professor, Department of Community Health and Family Medicine, College of Medicine, and Clinical Assistant Professor, Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville.
Dietrich E; Kyle A. Davis, Pharm.D., BCPS, is Clinical Hospital Pharmacist, Internal Medicine; and Marta A. Miyares, Pharm.D., BCPS (AQ-Cardiology), CACP, is Clinical Hospital Pharmacist, Internal Medicine, Jackson Memorial Hospital, Miami, FL. Eric Dietrich, Pharm.D., BCPS, is Clinical Assistant Professor, Department of Community Health and Family Medicine, College of Medicine, and Clinical Assistant Professor, Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville.; Pokaż więcej
Źródło:: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2015 Oct 01; Vol. 72 (19), pp. 1623-9.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Aspirin/*therapeutic use
Ischemic Attack, Transient/*prevention & control
Platelet Aggregation Inhibitors/*therapeutic use
Stroke/*prevention & control
Ticlopidine/*analogs & derivatives
Aspirin/administration & dosage ; Atherosclerosis/physiopathology ; Blood Platelets/metabolism ; Clopidogrel ; Drug Therapy, Combination ; Humans ; Ischemic Attack, Transient/physiopathology ; Multicenter Studies as Topic ; Platelet Aggregation Inhibitors/administration & dosage ; Randomized Controlled Trials as Topic ; Secondary Prevention ; Severity of Illness Index ; Stroke/physiopathology ; Ticlopidine/administration & dosage ; Ticlopidine/therapeutic use ; Time Factors

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Comparing prasugrel to twice daily clopidogrel post percutaneous coronary intervention in a Veterans Affairs population.
Autorzy:: Khatri S; Clinical Pharmacist, Richard L. Roudebush VA Medical Center, Indianapolis, IN .
Pierce T; Critical Care Clinical Pharmacy Specialist, Richard L. Roudebusch VA Medical Center, Indianapolis, IN.; Pokaż więcej
Źródło:: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2015 Sep 01; Vol. 72 (17 Suppl 2), pp. S98-S103.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Cardiovascular Diseases/*epidemiology
Percutaneous Coronary Intervention/*methods
Platelet Aggregation Inhibitors/*therapeutic use
Prasugrel Hydrochloride/*therapeutic use
Ticlopidine/*analogs & derivatives
Aged ; Clopidogrel ; Female ; Hemorrhage/prevention & control ; Humans ; Male ; Middle Aged ; Myocardial Infarction/epidemiology ; Platelet Aggregation Inhibitors/adverse effects ; Prasugrel Hydrochloride/adverse effects ; Retrospective Studies ; Stroke/epidemiology ; Ticlopidine/adverse effects ; Ticlopidine/therapeutic use ; United States ; United States Department of Veterans Affairs

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Isolation and Structural Elucidation of an Unknown Impurity in Prasugrel by Semi-Preparative Liquid Chromatography.
Autorzy:: Liu C; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang Province, China Zhejiang Charioteer Pharmaceutical Co. Ltd., Tongyuanxi, Dazhan, Xinju County, Zhejiang Province, China.
Yu Z; Zhejiang Charioteer Pharmaceutical Co. Ltd., Tongyuanxi, Dazhan, Xinju County, Zhejiang Province, China.
Wang F; Zhejiang Charioteer Pharmaceutical Co. Ltd., Tongyuanxi, Dazhan, Xinju County, Zhejiang Province, China.
Zhong X; Zhejiang Charioteer Pharmaceutical Co. Ltd., Tongyuanxi, Dazhan, Xinju County, Zhejiang Province, China.
Jiang L; Zhejiang Charioteer Pharmaceutical Co. Ltd., Tongyuanxi, Dazhan, Xinju County, Zhejiang Province, China.
Zhang F; Zhejiang Charioteer Pharmaceutical Co. Ltd., Tongyuanxi, Dazhan, Xinju County, Zhejiang Province, China.
Tang Y; Zhejiang Charioteer Pharmaceutical Co. Ltd., Tongyuanxi, Dazhan, Xinju County, Zhejiang Province, China.
Yan Z; Zhejiang Charioteer Pharmaceutical Co. Ltd., Tongyuanxi, Dazhan, Xinju County, Zhejiang Province, China.
Zeng S; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang Province, China.
Pu T; Zhejiang Charioteer Pharmaceutical Co. Ltd., Tongyuanxi, Dazhan, Xinju County, Zhejiang Province, China .; Pokaż więcej
Źródło:: Journal of chromatographic science [J Chromatogr Sci] 2015 Aug; Vol. 53 (7), pp. 1163-8. Date of Electronic Publication: 2015 Feb 01.
Typ publikacji:: Journal Article
MeSH Terms:: Chromatography, High Pressure Liquid*/methods
Drug Contamination*
Platelet Aggregation Inhibitors/*chemistry
Prasugrel Hydrochloride/*chemistry
Chromatography, Reverse-Phase/methods ; Magnetic Resonance Spectroscopy/methods ; Platelet Aggregation Inhibitors/isolation & purification ; Prasugrel Hydrochloride/isolation & purification

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Biochemical and functional characterization of Bothropoidin: the first haemorrhagic metalloproteinase from Bothrops pauloensis snake venom.
Autorzy:: Gomes MS; Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil .b.
Naves de Souza DL; Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil.
Guimarães DO; Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil.
Lopes DS; Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil.
Mamede CC; Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil.
Gimenes SN; Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil.
Achê DC; Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil.
Rodrigues RS; Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil.
Yoneyama KA; Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil.
Borges MH; Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil.
de Oliveira F; Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil.
Rodrigues VM; Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil .; Pokaż więcej
Źródło:: Journal of biochemistry [J Biochem] 2015 Mar; Vol. 157 (3), pp. 137-49. Date of Electronic Publication: 2014 Sep 26.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Anticoagulants/*pharmacology
Metalloproteases/*pharmacology
Platelet Aggregation Inhibitors/*pharmacology
Reptilian Proteins/*pharmacology
Snake Venoms/*enzymology
Amino Acid Sequence ; Animals ; Anticoagulants/chemistry ; Anticoagulants/isolation & purification ; Bothrops ; Cattle ; Cell Line, Tumor ; Cell Survival/drug effects ; Chromatography, Ion Exchange ; Fibrinogen/chemistry ; Hemorrhage/chemically induced ; Hydrolysis ; Metalloproteases/chemistry ; Metalloproteases/isolation & purification ; Mice, Inbred BALB C ; Molecular Sequence Data ; Platelet Aggregation Inhibitors/chemistry ; Platelet Aggregation Inhibitors/isolation & purification ; Proteolysis ; Reptilian Proteins/chemistry ; Reptilian Proteins/isolation & purification ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization